TITLE

Fatty Aspirin: A New Perspective in the Prevention of Dementia of Alzheimer's Type?

AUTHOR(S)
Pomponi, Massimiliano; Gioia, Annamaria D.; Bria, Pietro; Lucio Pomponi, Massimo Fabio
PUB. DATE
December 2008
SOURCE
Current Alzheimer Research;Dec2008, Vol. 5 Issue 5, p422
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Alzheimer's disease (AD) leads to a dramatic decline in cognitive abilities and memory. A more modest disruption of memory often occurs in normal aging and the same circuits that are devastated through degeneration in AD are vulnerable to sub-lethal age-related changes that alter synaptic transmission. There are numerous indications that aberrant plasticity is critically involved in Alzheimer's. Is ageing itself the major risk factor for AD? Is AD an acceleration of normal ageing? We assume that the ability of the brain is to modify its own structural organization and functioning which is liable to become impaired in ageing until it becomes dramatically impaired in Alzheimer's. Moreover, ageing can compromise the conversion of dietary alpha-linolenic acid (ALA) to docosahexaenoic acid (DHA). DHA regulates synaptogenesis and affects the synaptic structure, and synapse density is reduced in ageing. DHA and newly identified DHAderived messenger, neuroprotecting D1 (NPD1), protect synapses and decrease the number of activated microglia in the hippocampal system. Delaying AD onset by a few years would reduce the number of the cases of dementia in the community. DHA (and NPD1?) and aspirin induce brain-derived neurotrophic factor (BDNF) protein expression and this protein has a crucial role in neuronal survival. The authors - in view of the increased neuroinflammatory reaction frequently observed during normal brain ageing - suggest the long-term use of �fatty aspirin�, an association of DHA and/or NPD1 and aspirin (or nitroaspirin), to postpone, or prevent, the structural neurodegeneration of the brain.
ACCESSION #
34561150

 

Related Articles

  • Scientists Unravel Neuroprotective Effects of Fish Oil. Wagner, Elizabeth // Life Extension;Dec2005, Vol. 11 Issue 12, p14 

    Reports on Louisiana State University scientists' claim that the omega-3 fatty acid docosahexaenoic acid (DHA) reduces levels of a protein known to cause damaging plaques in the brains of Alzheimer's patients, and a derivative of DHA helps protect brain cells against cell death. Sources of DHA;...

  • What was lost in translation in the DHA trial is whom you should intend to treat. Frautschy, Sally A.; Cole, . Cole // Alzheimer's Research & Therapy;2011, Vol. 3 Issue 1, p1 

    The results of a randomized double-blind placebo-controlled trial with docosahexaenoic acid (DHA) supplementation in mild to moderate Alzheimer's disease (AD) published by Quinn and colleagues in JAMA argues against overall efficacy of DHA in slowing progression. However, certain caveats in the...

  • The good fat.  // Pharmaceutical Representative;Feb2008, Vol. 38 Issue 2, p9 

    The article presents a study led by Greg Cole, associate director of the University of California at Los Angeles' Alzheimer Disease Research Center which revealed that a diet rich in docosahexaenoic acid (DHA), an omega-3 fatty acid, may help prevent Alzheimer's disease or delay its onset in the...

  • EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW. de Souza Fernandes, Dalila Pinto; Canaan Rezende, Fabiane Aparecida; Rocha, Gabriele Pereira; De Santis Filgueiras, Mariana; Silva Moreira, Patrícia Regina; de Cássia Gonçalves Alfenas, Rita; Pereira Rocha, Gabriele; Gonçalves Alfenas, Rita de Cássia // Nutricion Hospitalaria;ago2015, Vol. 32 Issue 2, p528 

    Introduction: there is a lack of consensus on the benefits of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) supplementations on cognition in dementia and/or Alzheimer's disease (AD) elderly.Objective: this study presents a systematic review of the results...

  • Long-Chain Omega-3 Fatty Acids and Optimization of Cognitive Performance. Muldoon, Matthew F.; Ryan, Christopher M.; Yao, Jeffrey K.; Conklin, Sarah M.; Manuck, Stephen B. // Military Medicine;Nov2014 Supplement, p95 

    Low consumption of the omega-3 fatty acids, eicosapentaenoic and docosahexaenonic acids, is linked to delayed brain development and, in late life, increased risk for Alzheimer’s disease. The current review focuses on cognitive functioning during midlife and summarizes available scientific...

  • Looking More Like Fish Is, Indeed, Brain Food.  // Tufts University Health & Nutrition Letter;Sep2003, Vol. 21 Issue 7, p1 

    Discusses the benefits from eating fish in reducing the risk for Alzheimer disease. Risk factors of Alzheimer's disease; Importance of docosahexaenoic acid (DHA) in phospholipids; Information on the recipe of Greens with Salmon, Dill, & Lemon Dressing.

  • THE DHA DEBATE. Vosburgh, Robert // SN: Supermarket News;Spring2008 Whole Health Supplement, Vol. 56, p20 

    The article focuses on the health benefit of Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, for adults. Major studies are under way to determine if DHA has any influence over age-related conditions like Alzheimer's disease; others recently evaluated its ability to prevent...

  • Boosting intake of omega-3 'could ward off' Alzheimer's. Tanday, Sanjay // GP: General Practitioner;3/27/2009, p9 

    The article cites a study which reveals that increasing dietary intake of omega-3 reduces the risk of developing Alzheimer's disease. The study, which involved mice that have been fed a diet enriched with docosahexaenoic acid (DHA), has shown that mice on a DHA diet did better in cognition...

  • Omega-3 Slashes Dementia Risk.  // Natural Life;Jan/Feb2007, Issue 113, p40 

    The article discusses how omega-3 fatty acid docosahexaenioc acid (DHA) is responsible for decreasing the risk of dementia and Alzheimer's disease. A study found that people who have higher levels of DHA in their blood have a 47% lower risk of developing dementia and Alzheimer's disease. Levels...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics